Live from the NIH registry
Studies recruiting near Lincoln right now
Top 25 of 155 recruiting studies, sorted by proximity — each links to its official registry page
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Saint Elizabeth Regional Medical Center — Lincoln, Nebraska (0.9 mi)
· Sponsor: NRG Oncology
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Narcolepsy Type 1, Narcolepsy Type 2
Phase 2, Phase 3
Interventional 786 participants sought
Alkermes Investigational Site — Lincoln, Nebraska (0.9 mi)
· Sponsor: Alkermes, Inc.
I-DECIDE After Bronchiolitis Hospitalization
Bronchiolitis Acute
N/A
Interventional 2,700 participants sought
Bryan Medical Center - Children's Nebraska Community site — Lincoln, Nebraska (0.9 mi)
· Sponsor: Seattle Children's Hospital
Pan-tumor MRD Study
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer
N/A
Observational 1,350 participants sought
Cancer Partners of Nebraska — Lincoln, Nebraska (0.9 mi)
· Sponsor: Paradigm Health
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
NHO Revive Research Institute, LLC ( Site 0121) — Lincoln, Nebraska (0.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Bipolar Disorder Type I With Mania
Phase 3
Interventional 450 participants sought
Local Institution - 0197 — Lincoln, Nebraska (0.9 mi)
· Sponsor: Bristol-Myers Squibb
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
HER2-positive Breast Cancer, Breast Cancer
Phase 2
Interventional 125 participants sought
Cancer Partners of Nebraska — Lincoln, Nebraska (0.9 mi)
· Sponsor: Jazz Pharmaceuticals
A Phase 1 Study of BLKR201 in Healthy Adult Participants
Healthy
Phase 1
Interventional 128 participants sought
Celerion — Lincoln, Nebraska (0.9 mi)
· Sponsor: Formation Bio, Inc.
A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02)
Septic Shock, Sepsis
Phase 3
Interventional 46 participants sought
Bryan Medical Center — Lincoln, Nebraska (0.9 mi)
· Sponsor: Vivacelle Bio
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
Clonal Mast Cell Disease, KIT D816V Mutation
N/A
Observational 750 participants sought
Somnos Clinical Research — Lincoln, Nebraska (0.9 mi)
· Sponsor: Blueprint Medicines Corporation
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Bipolar Depression
Phase 3
Interventional 384 participants sought
Alivation Research LLC — Lincoln, Nebraska (0.9 mi)
· Sponsor: Intra-Cellular Therapies, Inc.
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Allergy Asthma & Immunology- Site Number : 8400044 — Lincoln, Nebraska (0.9 mi)
· Sponsor: Sanofi
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Schizophrenia
N/A
Observational 1,500 participants sought
Local Institution - 0041 — Lincoln, Nebraska (0.9 mi)
· Sponsor: Bristol-Myers Squibb
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Multiple Myeloma
Phase 3
Interventional 1,060 participants sought
NHO Revive Research Institute, LLC — Lincoln, Nebraska (0.9 mi)
· Sponsor: Pfizer
A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors
Solid Tumor, Adult
Phase 1, Phase 2
Interventional 348 participants sought
Nebraska Hematology Oncology — Lincoln, Nebraska (0.9 mi)
· Sponsor: Corbus Pharmaceuticals Inc.
ACP-204 in Adults With Alzheimer's Disease Psychosis
Alzheimer's Disease Psychosis
Phase 2, Phase 3
Interventional 1,074 participants sought
Alivation Research, LLC — Lincoln, Nebraska (0.9 mi)
· Sponsor: ACADIA Pharmaceuticals Inc.
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Phase 3
Interventional 351 participants sought
Nebraska Hematology Oncology — Lincoln, Nebraska (0.9 mi)
· Sponsor: BeOne Medicines
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Nebraska Hematology and Oncology — Lincoln, Nebraska (0.9 mi)
· Sponsor: SWOG Cancer Research Network
A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years
Healthy Adult Male and Female Volunteers
Phase 1
Interventional 212 participants sought
Celerion — Lincoln, Nebraska (0.9 mi)
· Sponsor: Centessa Pharmaceuticals (UK) Limited
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Schizophrenia, Bipolar Disorder
Phase 3
Interventional 300 participants sought
Alivation Research LLC — Lincoln, Nebraska (0.9 mi)
· Sponsor: Intra-Cellular Therapies, Inc.
Effectiveness of Plaque Score Detection Techniques
Plaque, Dental
N/A
Observational 50 participants sought
University of Nebraska Medical Center Dental College — Lincoln, Nebraska (0.9 mi)
· Sponsor: University of Nebraska
Assessment of CCM in HF With Higher Ejection Fraction
Heart Failure, Heart Failure With Preserved Ejection Fraction
N/A
Interventional 1,500 participants sought
Bryan Heart — Lincoln, Nebraska (0.9 mi)
· Sponsor: Impulse Dynamics
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Intracranial Meningioma, Recurrent Meningioma
Phase 2
Interventional 124 participants sought
Saint Elizabeth Regional Medical Center — Lincoln, Nebraska (0.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Phase 3
Interventional 2,500 participants sought
Anthos Investigative Site 1066 — Lincoln, Nebraska (0.9 mi)
· Sponsor: Anthos Therapeutics, Inc.
A Study of V132 in Healthy Older Participants (V132-001)
Healthy
Phase 1
Interventional 280 participants sought
Velocity Clinical Research Lincoln ( Site 0007) — Lincoln, Nebraska (0.9 mi)
· Sponsor: Merck Sharp & Dohme LLC